Octagon Capital Advisors as of March 31, 2023
Portfolio Holdings for Octagon Capital Advisors
Octagon Capital Advisors holds 35 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Apellis Pharmaceuticals (APLS) | 30.8 | $214M | 3.3M | 65.96 | |
| Chinook Therapeutics | 8.5 | $59M | 2.6M | 23.15 | |
| Verona Pharma Sponsored Ads (VRNA) | 7.1 | $50M | 2.5M | 20.08 | |
| Cymabay Therapeutics | 5.7 | $40M | 4.6M | 8.72 | |
| Arcus Biosciences Incorporated (RCUS) | 5.7 | $40M | 2.2M | 18.24 | |
| Miragen Therapeutics (VRDN) | 4.3 | $30M | 1.2M | 25.44 | |
| Roivant Sciences SHS (ROIV) | 4.1 | $29M | 3.9M | 7.38 | |
| Mirati Therapeutics | 4.0 | $28M | 750k | 37.18 | |
| Celldex Therapeutics Com New (CLDX) | 3.9 | $27M | 760k | 35.98 | |
| Bridgebio Pharma (BBIO) | 3.4 | $24M | 1.4M | 16.58 | |
| Tandem Diabetes Care Com New (TNDM) | 2.8 | $19M | 475k | 40.61 | |
| Aerovate Therapeutics (AVTE) | 1.8 | $13M | 622k | 20.17 | |
| Jasper Therapeutics | 1.7 | $12M | 6.4M | 1.81 | |
| Travere Therapeutics (TVTX) | 1.6 | $11M | 495k | 22.49 | |
| Alpine Immune Sciences | 1.3 | $9.3M | 1.2M | 7.72 | |
| 4d Molecular Therapeutics In (FDMT) | 1.2 | $8.6M | 500k | 17.19 | |
| Iteos Therapeutics (ITOS) | 1.2 | $8.1M | 596k | 13.61 | |
| Dyne Therapeutics (DYN) | 1.1 | $8.0M | 693k | 11.52 | |
| Xilio Therapeutics (XLO) | 1.1 | $7.7M | 2.4M | 3.17 | |
| Viking Therapeutics (VKTX) | 0.9 | $6.2M | 375k | 16.65 | |
| Vera Therapeutics Cl A (VERA) | 0.9 | $6.2M | 795k | 7.76 | |
| 89bio (ETNB) | 0.9 | $6.1M | 400k | 15.23 | |
| Avidity Biosciences Ord (RNA) | 0.8 | $5.9M | 382k | 15.35 | |
| Intra Cellular Therapies (ITCI) | 0.7 | $5.1M | 95k | 54.15 | |
| Geron Corporation (GERN) | 0.7 | $4.9M | 2.3M | 2.17 | |
| Aclaris Therapeutics (ACRS) | 0.7 | $4.7M | 577k | 8.09 | |
| Annexon (ANNX) | 0.7 | $4.6M | 1.2M | 3.85 | |
| Glycomimetics (GLYC) | 0.5 | $3.8M | 3.0M | 1.26 | |
| Reneo Pharmaceuticals (RPHM) | 0.4 | $2.5M | 420k | 5.98 | |
| Gossamer Bio (GOSS) | 0.4 | $2.5M | 2.0M | 1.26 | |
| Structure Therapeutics Sponsored Ads (GPCR) | 0.3 | $2.2M | 94k | 23.79 | |
| Stoke Therapeutics (STOK) | 0.2 | $1.5M | 186k | 8.33 | |
| Centessa Pharmaceuticals Sponsored Ads (CNTA) | 0.2 | $1.5M | 396k | 3.85 | |
| Vectivbio Hldg Ord Shs | 0.0 | $300k | 35k | 8.51 | |
| Pieris Pharmaceuticals | 0.0 | $294k | 302k | 0.98 |
